Benzinga's Top Upgrades, Downgrades For January 4, 2017

Loading...
Loading...

Top Upgrades

  • Analysts at Evercore ISI Group upgraded Charles River Laboratories Intl. Inc CRL from Hold to Buy. Charles River shares rose 0.45 percent to close at $76.53 on Tuesday.
  • Deutsche Bank upgraded HollyFrontier Corp HFC from Hold to Buy. HollyFrontier shares rose 2.47 percent to close at $33.57 on Tuesday.
  • Baird upgraded Aecom ACM from Neutral to Outperform. AECOM shares rose 1.3 percent to $37.48 in pre-market trading.
  • Analysts at FBR Capital upgraded Abercrombie & Fitch Co. ANF from Underperform to Market Perform. Abercrombie & Fitch shares rose 1.07 percent to $12.24 in pre-market trading.
  • Piper Jaffray upgraded Hologic, Inc. HOLX from Neutral to Overweight. Hologic shares rose 0.10 percent to close at $40.16 on Tuesday.
  • Analysts at Goldman Sachs upgraded ON Semiconductor Corp ON from Neutral to Buy. ON Semiconductor shares gained 2.92 percent to $13.05 in pre-market trading.
  • Loop Capital upgraded Canadian Pacific Railway Limited (USA) CP from Hold to Buy. Canadian Pacific Railway shares fell 0.94 percent to close at $141.43 on Tuesday.
  • Goldman Sachs upgraded State Street Corp STT from Neutral to Buy. State Street shares rose 1.97 percent to close at $79.25 on Tuesday.
  • Analysts at Barclays upgraded Agilent Technologies Inc A from Equal-Weight to Overweight. Agilent shares rose 0.71 percent to $46.82 in pre-market trading.
  • Analysts at Bank of America upgraded Altria Group Inc MO from Neutral to Buy.. Altria Group shares rose 1 percent to $68.30 in pre-market trading.


Top Downgrades

  • Goldman Sachs downgraded BlackRock, Inc. BLK from Buy to Neutral. BlackRock shares fell 0.40 percent to $384.89 in pre-market trading.
  • Stifel Nicolaus downgraded Anthem Inc ANTM from Buy to Hold. Anthem shares fell 0.37 percent to close at $143.24 on Tuesday.
  • Analysts at Cowen & Co. downgraded JetBlue Airways Corporation JBLU from Outperform to Market Perform. JetBlue shares fell 0.31 percent to $22.32 in pre-market trading.
  • Deutsche Bank downgraded Noble Energy, Inc. NBL from Buy to Hold. Noble Energy shares rose 0.97 percent to close at $38.43 on Tuesday.
  • Credit Suisse downgraded Baker Hughes Incorporated BHI from Outperform to Neutral. Baker Hughes shares rose 0.09 percent to close at $65.03 on Tuesday.
  • Analysts at Evercore ISI Group downgraded Intuitive Surgical, Inc. ISRG from Buy to Hold. Intuitive Surgical shares fell 0.59 percent to $638.00 in pre-market trading.
  • Goldman Sachs downgraded Microsemi Corporation MSCC from Buy to Neutral. Microsemi shares rose 1.13 percent to close at $54.58 on Tuesday.
  • Analysts at Imperial Capital downgraded Zebra Technologies Corp. ZBRA from Outperform to In-Line. Zebra Technologies shares rose 0.57 percent to close at $86.25 on Tuesday.
  • DA Davidson downgraded J & J Snack Foods Corp JJSF from Buy to Neutral. J&J Snack shares fell 0.47 percent to close at $132.80 on Tuesday.
  • Bank of America downgraded Philip Morris International Inc. PM from Buy to Neutral. Philip Morris shares fell 0.73 percent to $90.56 in pre-market trading.


Top Initiations

  • Analysts at UBS initiated coverage on Athene Holding Ltd ATH with a Neutral rating. The price target for Athene Holding is set to $52. Athene Holding shares closed at $47.82 on Tuesday.
  • Analysts at Leerink Swann initiated coverage on Achaogen Inc AKAO with an Outperform rating. The price target for Achaogen is set to $21. Achaogen shares closed at $13.00 on Tuesday.
  • Analysts at Craig-Hallum initiated coverage on Fusion Telecommunications Int'l, Inc. FSNN with a Buy rating. The price target for Fusion Telecommunications is set to $3. Fusion Telecommunications shares closed at $1.45 on Tuesday.
  • Analysts at Rodman & Renshaw initiated coverage of Ritter Pharmaceuticals Inc RTTR with a Buy rating. The price target for Ritter Pharmaceuticals is set to $7. Ritter Pharmaceuticals shares closed at $2.89 on Tuesday.
  • Analysts at Roth Capital initiated coverage on Kite Pharma Inc KITE with a Buy rating. The price target for Kite Pharma is set to $68. Kite Pharma shares closed at $45.95 on Tuesday.
  • Analysts at Canaccord Genuity initiated coverage on Teladoc Inc TDOC with a Buy rating. The price target for Teladoc is set to $24. Teladoc shares closed at $16.50 on Tuesday.
  • Analysts at JPMorgan initiated coverage on Global Blood Therapeutics Inc GBT with an Overweight rating. The price target for Global Blood Therapeutics is set to $25. Global Blood Therapeutics shares closed at $14.30 on Tuesday.
Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationAnalyst RatingsDowngradesEnergyInitiationsOil & Gas Exploration & Productiontop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...